HAINAN POLY PHARMHH

HAINAN POLY PHARM

2.49CNY
−0.02−0.80%
3월 25일 00:49 GMT 에 마감 때
CNY
거래 없음
슈퍼차트에서 보기

300630 펀더멘털

HAINAN POLY PHARM 수익 내역 개요

수익 수치에 가장 큰 기여를 한 국가는 중국로, 지난 해에는 HAINAN POLY PHARM 1.15 B CNY를 냈으며, 그리고 그 앞 해에는 1.51 B CNY를 냈습니다.

소스별
2016
2017
2018
2019
2020
2021
2022
2023
‪0.00‬
‪‪500.00 M‬‬
‪‪1.00 B‬‬
‪‪1.50 B‬‬
‪‪2.00 B‬‬
Non-steroidal Anti-inflammatory Drugs
Antibiotics
Allergy Medications
Cardiovascular Drugs
First Aid Medicine
Skin Disease Drugs
Digestive Tract Drugs
Other
Dexamethasone Dispersible Tablets
Diclofenac Sodium Enteric Sustained Release Capsules
Dexamethasone Dry Suspension
Clarithmromycin Sustained Release Tablets
Maleic Acid Tricamundine Tablets
Other Business
Levofloxacin Hydrochloride Capsules
Azithromycin Dry Suspensin
Desloratadine Tablets
통화: CNY
2016
2017
2018
2019
2020
2021
2022
2023
Non-steroidal Anti-inflammatory Drugs
‪‪85.47 M‬‬
‪‪115.06 M‬‬
‪‪118.62 M‬‬
‪‪128.76 M‬‬
‪‪523.74 M‬‬
Antibiotics
‪‪244.54 M‬‬
‪‪231.33 M‬‬
‪‪446.76 M‬‬
‪‪434.61 M‬‬
‪‪212.77 M‬‬
Allergy Medications
‪‪315.89 M‬‬
‪‪219.62 M‬‬
‪‪293.81 M‬‬
‪‪262.08 M‬‬
‪‪186.62 M‬‬
Cardiovascular Drugs
‪‪338.59 M‬‬
‪‪266.11 M‬‬
‪‪330.87 M‬‬
‪‪119.93 M‬‬
First Aid Medicine
‪‪164.02 M‬‬
‪‪78.89 M‬‬
Skin Disease Drugs
‪‪46.63 M‬‬
‪‪78.60 M‬‬
‪‪69.55 M‬‬
‪‪66.18 M‬‬
Digestive Tract Drugs
‪‪34.77 M‬‬
‪‪119.61 M‬‬
‪‪155.38 M‬‬
‪‪236.28 M‬‬
‪‪58.27 M‬‬
Other
‪‪269.42 M‬‬
‪‪117.77 M‬‬
‪‪149.55 M‬‬
‪‪180.19 M‬‬
‪‪58.08 M‬‬
Dexamethasone Dispersible Tablets
Diclofenac Sodium Enteric Sustained Release Capsules
Dexamethasone Dry Suspension
Clarithmromycin Sustained Release Tablets
Maleic Acid Tricamundine Tablets
Other Business
Levofloxacin Hydrochloride Capsules
Azithromycin Dry Suspensin
Desloratadine Tablets
국가별
2016
2017
2018
2019
2020
2021
2022
2023
‪0.00‬
‪‪500.00 M‬‬
‪‪1.00 B‬‬
‪‪1.50 B‬‬
‪‪2.00 B‬‬
China
Overseas
통화: CNY
2016
2017
2018
2019
2020
2021
2022
2023
China
‪‪863.70 M‬‬
‪‪1.02 B‬‬
‪‪1.28 B‬‬
‪‪1.51 B‬‬
‪‪1.15 B‬‬
Overseas
‪‪86.39 M‬‬
‪‪164.22 M‬‬
‪‪231.35 M‬‬
‪‪295.13 M‬‬
‪‪151.87 M‬‬